Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:42:41.273Z.
Calculation as of: 2026-10-06T15:42:41.273Z.
Quote observation: 2026-10-06T15:40:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47811cd6fce140e68777d2609bf88a35ade871fb75fdb0cf4ca3c33c868081b2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Medicus Pharma Ltd. Common Stock
Market Cap
$10.08M
EV/FCF Ratio
N/A
| NAME | MARKET CAP | EV/FCF RATIO |
|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.08M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.80M | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.36M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.68M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.47M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.53M | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.57M | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.22M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.29M | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
